Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Everything You Need to Know About Supervision

Feb 1, 2025/Feature

Changes to Medicare in 2025 will impact requirements for PT supervision of PTAs. Do they make direct supervision obsolete?

New Technology: Keeping It Ethical, Keeping It Legal

Nov 1, 2019/Feature

Advances in health care technology raise legal and ethical issues. Here are some situations you soon may encounter, if you haven't already. How should you respond?

Get to Know APTA Home Health: An Interview With Academy President Philip Goldsmith

Dec 10, 2024/Podcast

A brief introduction from the president of the academy.

APTA Outstanding Research Award

Awards

This award encourages the publication of outstanding physical therapy research articles, including both foundational and clinical research impacting practice and patient care.

New Study Reimagines the Relationship Between Daily Steps and Health Outcomes

Sep 3, 2025/Article

For decades, 10,000 steps a day has been regarded as a near-universal benchmark for fitness and general health goals — often promoted by wearable fitness trackers and public health campaigns. However, an August 2025 study, "Daily steps and health outcomes in adults: a systematic review and dose-response

Global Physical Therapy Day of Service

Do something to make a difference on Oct. 12, 2023.

Coronavirus Update: March 30, 2020

Mar 30, 2020/News

Practice guidance for pediatric physical therapy, a new volunteer resource, accelerated Medicare payments, and more.

New Member Benefit a One-Stop-Shop for Prior Authorization, UM Advocacy Tools

Mar 15, 2022/News

APTA and the Private Practice Section have collaborated to create SPARC — the State Payer Advocacy Resource Center.

What Is PTPAC? Five Things You Need to Know

Feb 3, 2023/News

Our political action committee is working on issues that matter now and into the profession's future.

Rivermead Mobility Index for Multiple Sclerosis (MS)

Sep 12, 2013/Test & Measure

Target population: People with multiple sclerosis (MS).